Point72 Asset Management, L.P. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,263,800
-92.8%
110,000
-86.3%
0.01%
-94.4%
Q3 2022$31,391,000
-22.8%
801,600
-36.3%
0.12%
-27.3%
Q2 2022$40,675,000
+178.7%
1,259,300
+185.6%
0.17%
+196.6%
Q1 2022$14,597,000
+1.8%
441,000
+30.9%
0.06%
+1.8%
Q4 2021$14,332,000
-57.3%
336,900
-55.5%
0.06%
-61.2%
Q3 2021$33,560,000
+158.9%
757,400
+231.9%
0.15%
+153.4%
Q2 2021$12,964,000
-48.1%
228,200
-31.6%
0.06%
-50.4%
Q1 2021$24,977,000
+35.2%
333,700
+10.4%
0.12%
+23.2%
Q3 2020$18,471,000
+260.8%
302,214
+145.4%
0.10%
+187.9%
Q2 2020$5,120,000
-79.2%
123,134
-52.0%
0.03%
-72.5%
Q4 2018$24,566,000
-0.6%
256,459
+46.5%
0.12%
+17.6%
Q3 2018$24,719,000
+12.8%
175,000
+25.0%
0.10%
+17.2%
Q2 2018$21,914,000
+32.6%
140,000
+36.5%
0.09%
+26.1%
Q1 2018$16,526,000
+77.6%
102,600
+81.6%
0.07%
+72.5%
Q4 2017$9,306,000
-61.2%
56,500
-85.3%
0.04%
-62.6%
Q3 2017$23,957,000
+140.7%
384,550
+207.6%
0.11%
+91.1%
Q2 2017$9,955,000
-64.6%
125,000
-68.4%
0.06%
-64.3%
Q1 2017$28,094,000
+753.1%
395,300
+512.9%
0.16%
+582.6%
Q4 2016$3,293,000
-57.1%
64,500
-61.3%
0.02%
-57.4%
Q3 2016$7,672,000
+51.8%
166,600
-0.7%
0.05%
+58.8%
Q2 2016$5,053,000167,7000.03%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,966,688$120,204,00010.81%
Integral Health Asset Management, LLC 230,000$14,058,0004.30%
Asymmetry Capital Management, L.P. 102,462$6,262,0004.02%
ACUTA CAPITAL PARTNERS, LLC 225,000$13,752,0003.74%
DAFNA Capital Management LLC 158,306$9,676,0003.14%
Bain Capital Life Sciences Investors, LLC 499,100$30,505,0002.84%
Boxer Capital, LLC 1,094,000$66,865,0002.31%
Palo Alto Investors LP 590,200$36,073,0001.98%
Logos Global Management LP 250,000$15,280,0001.96%
Bellevue Group AG 1,579,504$96,539,0001.33%
View complete list of SAGE THERAPEUTICS INC shareholders